FDA Adverse Event Injury Summary report: N

PERCLOSE PROGLIDE¿

MDR report key: 20858495 · Received December 5, 2024

Report

Report Number
2024168-2024-14316
Event Type
Injury
Date Received
December 5, 2024
Date of Event
September 25, 2024
Report Date
February 13, 2025
Manufacturer
ABBOTT VASCULAR INC.
Product Code
MGB
UDI-DI
08717648113154
PMA / PMN Number
P960043
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

MANUFACTURER'S INVESTIGATION IS STILL PENDING AT THIS TIME. RESULTS AND CONCLUSIONS WILL BE PROVIDED IN THE FINAL REPORT. H6: MEDICAL DEVICE PROBLEM CODE 2017 - FAILURE TO FOLLOW STEPS / INSTRUCTIONS.

Additional Manufacturer Narrative · 0

AN ANALYSIS WAS PERFORMED ON THE RETURNED DEVICE. THE BREAK WAS NOT CONFIRMED. PRODUCTION RECORD AND CORRECTIVE AND PREVENTATIVE ACTIONS (CAPA) REVIEWS WERE PERFORMED AND REVEALED NO INDICATION OF A PRODUCT QUALITY ISSUE. ADDITIONALLY, A QUERY OF THE COMPLAINT HANDLING DATABASE FOR THE REPORTED LOT REVEALED THERE IS NO INDICATION OF A LOT SPECIFIC ISSUE. REPORTEDLY, NO ANGIOGRAM WAS USED PRIOR TO USE. IT SHOULD BE NOTED THE ELECTRONIC PROGLIDE INSTRUCTIONS FOR USE (IFU), STATES: ¿PERFORM A FEMORAL ANGIOGRAM TO VERIFY THE LOCATION OF THE PUNCTURE SITE. IN THIS CASE, IT IS UNKNOWN IF THE REPORTED VIOLATION OF THE IFU CAUSED THE REPORTED DIFFICULTIES. BASED ON THE REPORTED INFORMATION AND THE OBSERVATIONS FROM THE RETURNED ANALYSIS, A DEFINITIVE CAUSE FOR THE REPORTED ISSUE COULD NOT BE DETERMINED. IT IS POSSIBLE THE FOOT WAS IN THE ACCESS SITE CAUSING ISSUES WITH THE LEVER; HOWEVER, THIS COULD NOT BE CONFIRMED. THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO THE DESIGN, MANUFACTURE, OR LABELING OF THE DEVICE. D4 CORRECTION: LOT # UPDATED FROM 3101043 TO 4030541

Description of Event or Problem · 0

IT WAS REPORTED THAT THIS WAS AN ARTERIOTOMY CLOSURE OF THE RIGHT COMMON FEMORAL ARTERY USING THE PRE-CLOSE TECHNIQUE VIA A 7F SHEATH HOLE PRIOR TO AN AORTIC VALVULAR REPLACEMENT INTERVENTIONAL PROCEDURE. REPORTEDLY, NO FEMORAL IMAGING WAS PERFORMED AND THE LEVER WAS BROKEN. THE SUTURES OF TWO NEW PROGLIDE DEVICES WERE SUCCESSFULLY PRE-PLACED. THE SHEATH WAS UPSIZED TO A 17F SHEATH AND THE AORTIC VALVULAR REPLACEMENT PROCEDURE WAS COMPLETED. HEMOSTASIS WAS ACHIEVED WITH THE PRE-PLACED PROGLIDE SUTURES. THERE WAS NO REPORTED ADVERSE PATIENT SEQUELA AND NO REPORTED CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE OR THERAPY. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2289826 PERCLOSE PROGLIDE¿ DEVICE, HEMOSTASIS, VASCULAR MGB ABBOTT VASCULAR INC. 12673-05 4030541 08717648113154

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention